Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 30064 | 8.76 |
09:34 ET | 3300 | 8.8 |
09:36 ET | 43354 | 8.88 |
09:38 ET | 7488 | 8.9501 |
09:39 ET | 8335 | 8.9 |
09:41 ET | 300 | 8.88 |
09:43 ET | 200 | 8.8882 |
09:45 ET | 1003 | 8.85 |
09:48 ET | 700 | 8.8 |
09:50 ET | 1779 | 8.83 |
09:54 ET | 590 | 8.8 |
09:56 ET | 858 | 8.81 |
09:59 ET | 475 | 8.8 |
10:01 ET | 100 | 8.82 |
10:03 ET | 100 | 8.818 |
10:06 ET | 627 | 8.82 |
10:08 ET | 100 | 8.82 |
10:10 ET | 2292 | 8.8297 |
10:12 ET | 4179 | 8.81 |
10:14 ET | 9033 | 8.8 |
10:15 ET | 1300 | 8.8 |
10:17 ET | 660 | 8.825 |
10:19 ET | 100 | 8.81 |
10:21 ET | 995 | 8.8 |
10:24 ET | 2359 | 8.79 |
10:26 ET | 1619 | 8.8 |
10:28 ET | 1159 | 8.79 |
10:30 ET | 5890 | 8.78 |
10:32 ET | 4187 | 8.781 |
10:33 ET | 8850 | 8.76 |
10:35 ET | 14765 | 8.76 |
10:37 ET | 4703 | 8.78 |
10:39 ET | 1816 | 8.76 |
10:42 ET | 1667 | 8.78 |
10:44 ET | 503 | 8.78 |
10:46 ET | 2290 | 8.81 |
10:48 ET | 2094 | 8.83 |
10:50 ET | 699 | 8.81 |
10:51 ET | 2129 | 8.79 |
10:53 ET | 2400 | 8.8273 |
10:55 ET | 1900 | 8.82 |
10:57 ET | 458 | 8.82 |
11:00 ET | 393 | 8.82 |
11:02 ET | 1441 | 8.8 |
11:04 ET | 1100 | 8.82 |
11:06 ET | 1452 | 8.79 |
11:08 ET | 200 | 8.8 |
11:09 ET | 719 | 8.8 |
11:11 ET | 1912 | 8.8 |
11:13 ET | 3983 | 8.7772 |
11:15 ET | 7200 | 8.8 |
11:18 ET | 1365 | 8.77 |
11:20 ET | 300 | 8.78 |
11:22 ET | 3530 | 8.7782 |
11:24 ET | 700 | 8.76 |
11:26 ET | 900 | 8.77 |
11:29 ET | 950 | 8.76 |
11:31 ET | 2559 | 8.77 |
11:33 ET | 5123 | 8.81 |
11:36 ET | 1050 | 8.78 |
11:38 ET | 3375 | 8.785 |
11:40 ET | 1310 | 8.76 |
11:42 ET | 1664 | 8.765 |
11:44 ET | 1100 | 8.76 |
11:45 ET | 4541 | 8.8 |
11:47 ET | 1355 | 8.79 |
11:49 ET | 2842 | 8.77 |
11:51 ET | 516 | 8.78 |
11:54 ET | 759 | 8.78 |
11:56 ET | 900 | 8.79 |
11:58 ET | 1000 | 8.81 |
12:00 ET | 2400 | 8.82 |
12:02 ET | 8569 | 8.85 |
12:03 ET | 20165 | 8.85 |
12:05 ET | 6500 | 8.79 |
12:07 ET | 1842 | 8.795 |
12:09 ET | 619 | 8.786 |
12:14 ET | 12426 | 8.8 |
12:16 ET | 1150 | 8.8 |
12:18 ET | 2016 | 8.8 |
12:20 ET | 2786 | 8.7801 |
12:21 ET | 2972 | 8.78 |
12:25 ET | 2701 | 8.8 |
12:27 ET | 6472 | 8.8 |
12:30 ET | 500 | 8.81 |
12:32 ET | 385 | 8.79 |
12:34 ET | 2086 | 8.8082 |
12:36 ET | 200 | 8.8 |
12:38 ET | 1458 | 8.79 |
12:39 ET | 5465 | 8.83 |
12:41 ET | 200 | 8.81 |
12:43 ET | 299 | 8.8 |
12:45 ET | 100 | 8.79 |
12:48 ET | 2755 | 8.77 |
12:50 ET | 100 | 8.78 |
12:52 ET | 447 | 8.762 |
12:54 ET | 1980 | 8.765 |
12:56 ET | 800 | 8.77 |
12:57 ET | 300 | 8.775 |
12:59 ET | 1910 | 8.775 |
01:01 ET | 293 | 8.76 |
01:03 ET | 300 | 8.77 |
01:06 ET | 550 | 8.76 |
01:08 ET | 300 | 8.77 |
01:12 ET | 2789 | 8.8 |
01:14 ET | 250 | 8.8 |
01:15 ET | 1822 | 8.82 |
01:17 ET | 1240 | 8.82 |
01:19 ET | 200 | 8.82 |
01:21 ET | 10154 | 8.85 |
01:24 ET | 2779 | 8.83 |
01:26 ET | 3774 | 8.85 |
01:28 ET | 1566 | 8.81 |
01:30 ET | 12130 | 8.82 |
01:32 ET | 2082 | 8.8 |
01:33 ET | 1036 | 8.8 |
01:35 ET | 1300 | 8.77 |
01:37 ET | 4099 | 8.77 |
01:39 ET | 1756 | 8.78 |
01:42 ET | 1389 | 8.78 |
01:44 ET | 500 | 8.78 |
01:46 ET | 920 | 8.78 |
01:48 ET | 3135 | 8.78 |
01:50 ET | 1300 | 8.785 |
01:51 ET | 1574 | 8.79 |
01:53 ET | 100 | 8.795 |
01:55 ET | 400 | 8.79 |
01:57 ET | 600 | 8.78 |
02:00 ET | 1519 | 8.79 |
02:02 ET | 500 | 8.78 |
02:04 ET | 2250 | 8.785 |
02:06 ET | 2000 | 8.81 |
02:08 ET | 700 | 8.81 |
02:09 ET | 2223 | 8.81 |
02:11 ET | 100 | 8.82 |
02:13 ET | 1344 | 8.83 |
02:18 ET | 100 | 8.84 |
02:20 ET | 1712 | 8.8576 |
02:22 ET | 1342 | 8.84 |
02:24 ET | 2453 | 8.86 |
02:26 ET | 2329 | 8.85 |
02:27 ET | 1651 | 8.87 |
02:29 ET | 600 | 8.87 |
02:31 ET | 2466 | 8.855 |
02:33 ET | 700 | 8.86 |
02:36 ET | 483 | 8.86 |
02:40 ET | 694 | 8.865 |
02:42 ET | 3223 | 8.86 |
02:44 ET | 400 | 8.87 |
02:45 ET | 2093 | 8.86 |
02:47 ET | 100 | 8.87 |
02:49 ET | 1014 | 8.87 |
02:51 ET | 3633 | 8.87 |
02:54 ET | 1650 | 8.88 |
02:56 ET | 6069 | 8.84 |
02:58 ET | 1100 | 8.84 |
03:00 ET | 481 | 8.835 |
03:02 ET | 2250 | 8.815 |
03:03 ET | 1231 | 8.79 |
03:07 ET | 1200 | 8.8 |
03:09 ET | 1575 | 8.8 |
03:12 ET | 312 | 8.76 |
03:14 ET | 100 | 8.76 |
03:16 ET | 944 | 8.78 |
03:18 ET | 2818 | 8.77 |
03:20 ET | 5220 | 8.77 |
03:23 ET | 100 | 8.77 |
03:25 ET | 1310 | 8.78 |
03:27 ET | 2000 | 8.77 |
03:30 ET | 1000 | 8.77 |
03:32 ET | 10141 | 8.775 |
03:34 ET | 1721 | 8.77 |
03:36 ET | 1410 | 8.78 |
03:38 ET | 2048 | 8.78 |
03:39 ET | 2534 | 8.78 |
03:41 ET | 900 | 8.79 |
03:43 ET | 870 | 8.795 |
03:45 ET | 4671 | 8.78 |
03:48 ET | 5041 | 8.795 |
03:50 ET | 3866 | 8.79 |
03:52 ET | 9660 | 8.815 |
03:54 ET | 8512 | 8.815 |
03:56 ET | 16236 | 8.895 |
03:57 ET | 12321 | 8.881 |
03:59 ET | 1289324 | 8.9 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.2B | -2.2x | --- |
Nurix Therapeutics Inc | 1.2B | -7.9x | --- |
Prothena Corporation PLC | 1.1B | -6.3x | --- |
Immatics NV | 1.2B | -11.1x | --- |
Arcutis Biotherapeutics Inc | 1.1B | -3.2x | --- |
Gyre Therapeutics Inc | 1.0B | -6.4x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2B |
---|---|
Revenue (TTM) | $79.6M |
Shares Outstanding | 136.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.47 |
EPS | $-4.01 |
Book Value | $11.80 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 15.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -780.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.